Clinical Trial Update: Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients With Acute Kidney Injury (AKI). [NA]

View source ↗

Summary

The clinical trial evaluating the Selective Cytopheretic Device (SCD) for safety and efficacy in pediatric acute kidney injury has completed, with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• Selective Cytopheretic Device (SCD)

Snippet

Sponsor: CytoPherx, Inc | Conditions: Acute Kidney Injury | NA | Status: COMPLETED | Results posted: 2024-06-20